The treatment given to this patient resulted in an improved microbiome with an increase in bacterial diversity, partly due to an increase in the relative abundance of butyrate-producing bacterial species, which were paralleled by an increase in butyrate concentration, an anti-inflammatory SCFA (Engen et al., 2020)
Laboratory research record on Glow | GHK-CU, TB-500, BPC-157 Blend [PMID: 27895400] PubMed laboratory record discussing Glow | GHK-CU, TB-500, BPC-157 Blend in a research context
Complementary mechanisms include increasing pancreatic -cell proliferation and reduces glucagon release which also contribute to an overall reduction in appetite
Advanced Peptide Research Supply Newsletter Signup Subscribe to receive updates on new compound releases, peer-reviewed literature developments, peptide research summaries, and key regulatory and compliance insights